SUNDARA PHARMACEUTICALS LTD
Significant control: Samer Taslaq (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Sundara Pharmaceuticals Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Sundara Pharmaceuticals Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
SUNDARA PHARMACEUTICALS LTD is an active private limited company (company number 11636445) incorporated on 23 October 2018, registered in Newcastle Upon Tyne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £147k and cash of £108k, with 1 employee on average. Net assets rose 46% on the prior period (£101k).
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Dr Samer Taslaq
- owns 25–50% of shares
- holds 25–50% of voting rights
- Leslie Anderson
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 23 October 20188 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 6 November 2026in 10 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £147k | £108k | £7 | £5,830 | — | — | 1 |
| 31 December 2024 | £101k | £61k | £873 | £5,800 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £147,399 at 31 December 2025
- Net assets up 10% or more on the prior period+46.3% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 18.56
- Cash at bank of £50,000 or moreCash £108,222
- Incorporated five or more years agoIncorporated 23 October 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 10 days
- Accounts period endNet assets £147k · small accounts
- Accounts period endNet assets £101k · small accounts
- Incorporated
Similar companies in Newcastle
- PRECISION IMMUNOTHERAPEUTICS LIMITEDNewcastle Upon Tyne · inc. Nov 2018
- NANOVERY LIMITEDNewcastle Upon Tyne · inc. Nov 2018
- PEPMOTEC LIMITEDDurham · inc. Feb 2019
- DEVELRX LIMITEDNewcastle Upon Tyne · inc. Jun 2019
- ALPHABIOMICS LTDNewcastle Upon Tyne · inc. Mar 2018
- TREAT-NMD ALLIANCE LTDNewcastle Upon Tyne · inc. Jul 2019
All companies incorporated on 23 October 2018 · in Oct 2018.
Reminders for SUNDARA PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.